awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-37435F54-5908-499E-BDAA-37DE7723FA29
Q33397131-37435F54-5908-499E-BDAA-37DE7723FA29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-37435F54-5908-499E-BDAA-37DE7723FA29
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P698
Q33397131-37435F54-5908-499E-BDAA-37DE7723FA29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-37435F54-5908-499E-BDAA-37DE7723FA29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a52baaf6bf2ff2e1ccbb54dc8f301578e0ce683
P698
21909644
http://www.w3.org/2001/XMLSchema#string